ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD

May 1, 1987

ACS President Huerta Disagrees With Staff On Cell Phone Danger.

August 1, 2008

American Radium Society Abstracts

July 23, 1976

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995